Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
61.
62.
AI may be making us think and write more alike
(news.ycombinator.com)
63.
LLM may be standardizing human expression – and subtly influencing how we think
(news.ycombinator.com)
64.
Neurocrine to Buy Soleno for Treatment for Rare Disease That Causes Relentless Hunger
(feeds.content.dowjones.io)
65.
Neurocrine to Buy Soleno for $2.9 Billion
(feeds.content.dowjones.io)
66.
67.
68.
A Growing Number of College Students Are Switching Majors — Here’s What’s Behind It
(feeds.feedburner.com)
69.
More self-reflection in research can lead to better science
(feeds.nature.com)
70.
Half of social-science studies fail replication test in years-long project
(feeds.nature.com)
71.
Reproducibility and robustness of economics and political science research
(feeds.nature.com)
72.
73.
Investigating the replicability of the social and behavioural sciences
(feeds.nature.com)
74.
Investigating the reproducibility of the social and behavioural sciences
(feeds.nature.com)
75.
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets
(feeds.content.dowjones.io)
76.
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
(feeds.content.dowjones.io)
78.
National Academies of Sciences says no to demands it remove climate info
(arstechnica.com)
79.
80.
Scientists revive activity in frozen mouse brains for the first time
(feeds.nature.com)
81.
How moss helped convict grave robbers of a Chicago cemetery
(arstechnica.com)
82.
83.
84.
Seeding opportunities for Black atmospheric scientists
(feeds.nature.com)
85.
A fentanyl vaccine is about to get its first major test
(arstechnica.com)
86.
China accounts for more than half of leading output in the applied sciences
(feeds.nature.com)